DexCom had 58 patents in internet of things during Q1 2024. DexCom Inc’s patents filed in Q1 2024 focus on systems and methods for processing sensor analyte data, remote monitoring, automatic suspension and resumption of medicament delivery, smart alerts for users regarding diabetic states, and transcutaneous measurement of glucose in a host. These patents aim to improve the accuracy, efficiency, and personalized nature of monitoring and managing health conditions such as diabetes. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights DexCom Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

DexCom grant share with internet of things as a theme is 22% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: System and methods for processing analyte sensor data for sensor calibration (Patent ID: US20240081693A1)

The patent by DexCom Inc. discloses systems and methods for processing sensor analyte data, focusing on calibration, updating, and evaluating the quality of sensor calibration. The calibration process involves using a calibration set of matched sensor and reference analyte data pairs, with initial calibration possible using reference data from benchtop testing or short-term continuous analyte sensors implanted in users. The method includes receiving sensor data, determining a conversion function with slope and baseline parameters based on prior distribution information, and converting the sensor data accordingly.

The claims detail a method and system for calibrating continuous analyte sensors, emphasizing the determination of conversion functions based on prior distribution information for slope and baseline parameters. The processor module selects the most probable slope and baseline from distributions, with prior information derived from in vivo or in vitro testing. The system involves a continuous analyte sensor providing data on analyte concentration, with the processor module responsible for determining and applying the conversion function. Overall, the patent aims to improve the accuracy and efficiency of sensor calibration processes for continuous analyte monitoring, particularly focusing on glucose concentration in hosts.

To know more about GlobalData’s detailed insights on DexCom, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.